Genetic Discrimination Observatory

Did You Know?

• The GDO staff comes from fields including genetics, ethics, law, sociology, and public policy.
• Initial funding was provided by Genome Canada (Génome Québec), the Fonds de recherche du Québec – Santé, and the Network of Applied Medical Genetics (RMGA).

Background

Genetic discrimination has become a multifaceted concern as genomic technologies are increasingly incorporated into healthcare. It occurs when individuals or groups are unfairly treated or harmed based on actual or presumed genetic characteristics, potentially infringing on human rights and undermining public trust in genetic services. In the postgenomic era, advances such as AI have made personal information more accessible, heightening the need to address genetic discrimination through adequate regulation.

Projects

The Genetic Discrimination Observatory (GDO) relies on research to build public understanding, shape policy, and measure how genetic discrimination affects society. Every year, the group runs both joint projects and studies led by its own members, all focused on spotting, stopping, and dealing with cases of genetic discrimination. Earlier work has looked at how to define genetic discrimination and what makes a good anti-discrimination policy. A major part of this effort is the GDO’s annual conference, where members share findings, talk about legal changes in different places, and discuss new policy ideas. That conference has helped spark many team and member research projects. One key study, published in JAMA Network Open, works to create a clear, broad definition of genetic discrimination that accounts for its widespread and stigmatizing effects. Another project set out to find the essential parts of a strong genetic non-discrimination policy and offer advice to lawmakers. A separate study goes beyond insurance underwriting to examine laws in 20 countries, figuring out which rules best balance scientific progress with privacy and ethics. Finally, a core team project, funded by the ACCESS Network and the Canadian Institute for Health Research, looks at the fears and real risks of genetic discrimination in pediatric oncology, especially for kids with rare cancers, and explores how human rights can help address those concerns.